Attila published his PhD in cellular and molecular immunology. He is a founding member of the Norwegian Association for Psychedelic Science and editor-in-chief of Journal of Psychedelic Studies. He is a pioneer in the field of psychedelic medicine

Israel is a biochemist who completed his degree and PhD from The Hebrew University of Jerusalem. He was a senior director of leading pharmaceutical company, GlaxoSmithKein where he led drug discovery programs for over thirty years. He specialises in molecular technologies and new therapeutic targets. He contributes his invaluable experience in the pharmaceutical space leading our international academic and industry collaborations

Marina is a molecular biologist with 15+ years in academia. She founded and successfully raised for her own startup, combining traditional drugs and nanotechnology for oncology

Laura is a drug development specialist and founder of Psylink. 8+ years in pharmacology, cell-based therapy research with exceptional knowledge of psychopharmacology and psychedelics

Biotechnologist specialized in Molecular Biology. Post Doctorate from Berkeley, University of California with vast experience in the Department of Molecular and Cell Biology. He has won the best Thesis of Neuroscience and the Gyorgi Buzaki price. He joined Alleece to investigate and understand how psychedelic drugs can target chronic inflammatory diseases.

Edelma is a pharmaceutical chemist with two decades experience in the pharmaceutical industry. She formulated and registered the first cannabis-based medicine in Uruguay, one of the first in the world. She contributes her extensive experience in drug development to our endeavours.

Mithi is a biotechnology enthrepreneur. He founded Camoxis Therapeutics, a neurovascular drug development program at the University of Cambridge, an agricultural biotechnology scale up ($60m+ growth captial)and bioinformatics start up ($6.5m seed)

Maria is a film producer and active entrepreneur. She founded and invested in successful media businesses including her own publishing company and award winning brands in fashion and F&B

Charles is a biomedic who specialises in healthcare marketing and communications. He has supported start up and spin-out companies to commercialise their innovative products and raise significant investments. He plays a vital role in commercialising our research into patentable drug candidates.

Gabriella specialises in strategy and communications. She graduated from King’s College University and went onto study experimental psychology at Oxford University and novel therapies for treating inflammation and drug delivery at Harvard Medical School